Positive trial results for Medicines Co.

The Medicines Company (Nasdaq: MDCO) and Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY) announced positive initial results from an ongoing Phase 1 clinical trial of ALN-PCSsc to treat hypercholesterolemia. Shares of The Medicines Company leaped $5.94 to $39.58 while Alnylam Pharmaceuticals stock tumbled $3.61 to $105.46.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.